Working… Menu

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02286089
Recruitment Status : Recruiting
First Posted : November 7, 2014
Last Update Posted : November 13, 2019
CellCure Neurosciences Ltd.
Information provided by (Responsible Party):
Lineage Cell Therapeutics, Inc.